711 related articles for article (PubMed ID: 17823525)
1. Epidermolysis bullosa acquisita following bullous pemphigoid, successfully treated with the anti-CD20 monoclonal antibody rituximab.
Wallet-Faber N; Franck N; Batteux F; Mateus C; Gilbert D; Carlotti A; Avril MF; Dupin N
Dermatology; 2007; 215(3):252-5. PubMed ID: 17823525
[TBL] [Abstract][Full Text] [Related]
2. Rituximab in refractory autoimmune bullous diseases.
Schmidt E; Hunzelmann N; Zillikens D; Bröcker EB; Goebeler M
Clin Exp Dermatol; 2006 Jul; 31(4):503-8. PubMed ID: 16716150
[TBL] [Abstract][Full Text] [Related]
3. [Successful use of combined corticosteroids and rituximab in the treatment of recalcitrant epidermolysis bullosa acquisita].
Cavailhes A; Balme B; Gilbert D; Skowron F
Ann Dermatol Venereol; 2009 Nov; 136(11):795-9. PubMed ID: 19917432
[TBL] [Abstract][Full Text] [Related]
4. Clinical response of severe mechanobullous epidermolysis bullosa acquisita to combined treatment with immunoadsorption and rituximab (anti-CD20 monoclonal antibodies).
Niedermeier A; Eming R; Pfütze M; Neumann CR; Happel C; Reich K; Hertl M
Arch Dermatol; 2007 Feb; 143(2):192-8. PubMed ID: 17309999
[TBL] [Abstract][Full Text] [Related]
5. A case of epidermolysis bullosa acquisita with clinical features of Brunsting-Perry pemphigoid showing an excellent response to colchicine.
Tanaka N; Dainichi T; Ohyama B; Yasumoto S; Oono T; Iwatsuki K; Elfert S; Fritsch A; Bruckner-Tuderman L; Hashimoto T
J Am Acad Dermatol; 2009 Oct; 61(4):715-9. PubMed ID: 19679376
[TBL] [Abstract][Full Text] [Related]
6. Successful adjuvant treatment of recalcitrant epidermolysis bullosa acquisita with anti-CD20 antibody rituximab.
Schmidt E; Benoit S; Bröcker EB; Zillikens D; Goebeler M
Arch Dermatol; 2006 Feb; 142(2):147-50. PubMed ID: 16490841
[No Abstract] [Full Text] [Related]
7. Case of concurrent epidermolysis bullosa acquisita and anti-p200 pemphigoid--how to treat it?
Pastar Z; Rados J; Lipozencic J; Dobric I; Marinovic B; Ishii N; Hashimoto T
Int J Dermatol; 2007 Mar; 46(3):295-8. PubMed ID: 17343589
[No Abstract] [Full Text] [Related]
8. Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita - Brazilian Society of Dermatology.
Santi CG; Gripp AC; Roselino AM; Mello DS; Gordilho JO; Marsillac PF; Porro AM
An Bras Dermatol; 2019 Apr; 94(2 Suppl 1):33-47. PubMed ID: 31166405
[TBL] [Abstract][Full Text] [Related]
9. Sustained clinical response to rituximab in a case of life-threatening overlap subepidermal autoimmune blistering disease.
Li Y; Foshee JB; Sontheimer RD
J Am Acad Dermatol; 2011 Apr; 64(4):773-8. PubMed ID: 20494477
[TBL] [Abstract][Full Text] [Related]
10. Epidermolysis bullosa acquisita: diagnosis by fluorescence overlay antigen mapping and clinical response to high-dose intravenous immunoglobulin.
Campos M; Silvente C; Lecona M; Suárez R; Lázaro P
Clin Exp Dermatol; 2006 Jan; 31(1):71-3. PubMed ID: 16309488
[TBL] [Abstract][Full Text] [Related]
11. Refractory epidermolysis bullosa acquisita: successful treatment with rituximab.
Saha M; Cutler T; Bhogal B; Black MM; Groves RW
Clin Exp Dermatol; 2009 Dec; 34(8):e979-80. PubMed ID: 20055876
[No Abstract] [Full Text] [Related]
12. Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases.
Lamberts A; Euverman HI; Terra JB; Jonkman MF; Horváth B
Front Immunol; 2018; 9():248. PubMed ID: 29520266
[TBL] [Abstract][Full Text] [Related]
13. A practical technique for differentiation of subepidermal bullous diseases: localization of in vivo-bound IgG by laser scanning confocal microscopy.
Wozniak K; Kazama T; Kowalewski C
Arch Dermatol; 2003 Aug; 139(8):1007-11. PubMed ID: 12925388
[TBL] [Abstract][Full Text] [Related]
14. Epidermolysis bullosa acquisita and anti-p200 pemphigoid as major subepidermal autoimmune bullous diseases diagnosed by floor binding on indirect immunofluorescence microscopy using human salt-split skin.
Goyal N; Rao R; Shenoi SD; Pai S; Kumar P; Bhogal BS; Schmidt E; Zillikens D
Indian J Dermatol Venereol Leprol; 2017; 83(5):550-555. PubMed ID: 28749386
[TBL] [Abstract][Full Text] [Related]
15. Bullous autoimmune dermatoses.
Hofmann SC; Juratli HA; Eming R
J Dtsch Dermatol Ges; 2018 Nov; 16(11):1339-1358. PubMed ID: 30395395
[TBL] [Abstract][Full Text] [Related]
16. Localized epidermolysis bullosa acquisita of the esophagus in a patient with Crohn's disease.
Schattenkirchner S; Lémann M; Prost C; Caux F; Guigui B; Cadot M; Bertheau P; Grateau C; Heller M
Am J Gastroenterol; 1996 Aug; 91(8):1657-9. PubMed ID: 8759686
[TBL] [Abstract][Full Text] [Related]
17. The use of skin substrates deficient in basement membrane molecules for the diagnosis of subepidermal autoimmune bullous disease.
Vodegel RM; Kiss M; Cjm De Jong M; Pas HH; Altmayer A; Molnar K; Husz S; Van Der Meer JB; Jonkman MF
Eur J Dermatol; 1998 Mar; 8(2):83-5. PubMed ID: 9649654
[TBL] [Abstract][Full Text] [Related]
18. Epidermolysis bullosa acquisita and associated symptomatic esophageal webs.
Stewart MI; Woodley DT; Briggaman RA
Arch Dermatol; 1991 Mar; 127(3):373-7. PubMed ID: 1998368
[TBL] [Abstract][Full Text] [Related]
19. Distinguishing Epidermolysis Bullosa Acquisita From Bullous Pemphigoid Without Direct Immunofluorescence.
Gardner KM; Crawford RI
J Cutan Med Surg; 2018; 22(1):22-24. PubMed ID: 28719980
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of epidermolysis bullosa acquisita, an autoimmune subepidermal bullous disease.
Hashimoto T; Ishii N; Ohata C; Furumura M
J Pathol; 2012 Sep; 228(1):1-7. PubMed ID: 22692770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
